Pictet Asset Management Ltd. lessened its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 0.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 141,097 shares of the company’s stock after selling 1,324 shares during the period. Pictet Asset Management Ltd.’s holdings in HCA Healthcare were worth $19,072,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in HCA. Steward Partners Investment Advisory LLC grew its holdings in HCA Healthcare by 2.1% in the second quarter. Steward Partners Investment Advisory LLC now owns 3,940 shares of the company’s stock valued at $532,000 after purchasing an additional 82 shares during the last quarter. Cornerstone Advisors Inc. grew its holdings in HCA Healthcare by 15.0% in the second quarter. Cornerstone Advisors Inc. now owns 675 shares of the company’s stock valued at $91,000 after purchasing an additional 88 shares during the last quarter. Commonwealth Bank of Australia grew its holdings in HCA Healthcare by 3.6% in the first quarter. Commonwealth Bank of Australia now owns 2,883 shares of the company’s stock valued at $374,000 after purchasing an additional 100 shares during the last quarter. Signaturefd LLC grew its holdings in HCA Healthcare by 7.1% in the first quarter. Signaturefd LLC now owns 1,863 shares of the company’s stock valued at $243,000 after purchasing an additional 123 shares during the last quarter. Finally, AE Wealth Management LLC grew its holdings in HCA Healthcare by 0.7% in the second quarter. AE Wealth Management LLC now owns 18,115 shares of the company’s stock valued at $2,449,000 after purchasing an additional 126 shares during the last quarter. 70.38% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have weighed in on HCA. Goldman Sachs Group raised HCA Healthcare from a “neutral” rating to a “buy” rating and upped their target price for the company from $147.00 to $160.00 in a report on Wednesday, July 10th. Bank of America upgraded HCA Healthcare from an “underperform” rating to a “neutral” rating and upped their price objective for the company from $130.00 to $137.00 in a research report on Friday, September 6th. UBS Group upped their price objective on HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Stephens set a $150.00 price objective on HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, August 7th. Finally, Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective on the stock. in a research report on Monday, May 27th. Three equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. HCA Healthcare currently has an average rating of “Buy” and an average target price of $155.29.
NYSE HCA traded up $0.81 during trading hours on Friday, hitting $129.51. 380,425 shares of the company’s stock were exchanged, compared to its average volume of 1,398,365. The business’s 50 day moving average is $126.91 and its 200-day moving average is $129.21. HCA Healthcare Inc has a 12-month low of $110.31 and a 12-month high of $147.42. The firm has a market capitalization of $44.36 billion, a P/E ratio of 13.26, a price-to-earnings-growth ratio of 1.11 and a beta of 0.87.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The business had revenue of $12.60 billion for the quarter, compared to analysts’ expectations of $12.61 billion. During the same quarter last year, the company posted $2.29 earnings per share. The business’s quarterly revenue was up 9.3% compared to the same quarter last year. On average, research analysts anticipate that HCA Healthcare Inc will post 10.4 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 annualized dividend and a yield of 1.24%. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.
In other news, SVP Robert A. Waterman sold 33,786 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total value of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at approximately $37,733,793.98. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Patricia F. Elcan acquired 250 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was purchased at an average price of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. Corporate insiders own 2.70% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: How prevalent are 12b-1 fees?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.